Clene (CLNN) Treasury Shares (2019)
Clene (CLNN) posted Treasury Shares of $27.5 million for Q4 2019.
Powered by 
Analysis
Clene (CLNN) Treasury Shares (2019) Analysis & Trends
Clene has reported Treasury Shares for 1 years, with the latest figure at $27.5 million in Q4 2019.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $27.5 million in Q4 2019; TTM through Dec 2019 was $27.5 million, a N/A change from a year earlier, with the FY2019 full-year figure at $27.5 million, changed N/A from the prior year.
- Treasury Shares was $27.5 million for Q4 2019 at Clene.
- The five-year high for Treasury Shares was $27.5 million in Q4 2019, with the low at $27.5 million in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 711.62 Mn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 77.11 Mn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 64.13 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -49.00 Mn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 3.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 35.35 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | - |